Manufacturer record

Nexkem Biotech Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Nexkem Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between December 2022 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Nexkem Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2022 to Nov 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2022
3
Products affected
Assay
Most common failure
Nov 2025
Latest alert

Flagged batches per year

2022 · 12024 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Amoxycillin & Potassium Clavulanate oral suspension IP NBD020AMfg 2025-02 · Exp 2026-07 The sample does not comply with the test for Assay of Amoxycillin and Clavulanic Acid and hence it is Not of Standard Quality.Assay DCL TelanganaState lab Nov 2025
Acepik - P (Aceclofenac and Paracetamol Tablets) NKT230962AMfg 2023-05 · Exp 2025-04 DisintegrationDisintegration CDL KolkataCDSCO lab Feb 2024
RamiRav Tablets (Ramipril Tablets I.P. 1.25 mg) NKT22116AMfg 2022-05 · Exp 2024-04 Dissolution & AssayAssay CDL KolkataCDSCO lab Dec 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.